Biotechnology Value Fund II, Director: Kymera Therapeutics KYMR Buy · Filed 23/11/06

Trade details

Type: Insider buy
Amount: $1,536,666.24
Shares · price: 132,016 sh · $11.64 a share
Held after: 2,020,367 sh
Stock: Kymera Therapeutics KYMR
Person: Biotechnology Value Fund IIDirector
Trade date: 23/11/02
Filed: 23/11/06
Days to filing: 4 days

10 insiders bought this week

Insiders buying this week: 10 insiders
Holding change: +7.0%

Kymera Therapeutics trades, last 26 weeks

What else happened in Kymera Therapeutics around then

Filed or reported within 30 days of the trade day · 23/10/03~23/12/02

Biotechnology Value Fund II's recent trades

Biotechnology Value Fund IIDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$89.2M
837,914 sh
$89.2M
Filed 06/26
Traded 06/26
Biotechnology Value Fund IIDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$66.8M
627,597 sh
$66.8M
Filed 06/26
Traded 06/26
Biotechnology Value Fund IIDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$12.1M
113,289 sh
$12.1M
Filed 06/26
Traded 06/26
Biotechnology Value Fund IIDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$5.5M
51,858 sh
$5.5M
Filed 06/26
Traded 06/26
Biotechnology Value Fund IIDirector
SellMoonLake Immunotherapeutics
Sell
MoonLake Immunotherapeutics
MLTX
$32.4M
1,932,354 sh
$32.4M
Filed 04/02
Traded 03/31

Biotechnology Value Fund II, Director — bought $1.5M of Kymera Therapeutics KYMR · 132,016 sh @ $11.64 | Whalegun